GlassScriptPhysician profile
Ryan R Bird
NPI 1043730492
$6,235.19
in general payments reported to CMS, 2019-2025
26 companies · $2,066 in 2025
The $2,066 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,169 · 2025: $2,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,380 · Travel and Lodging: $1,759 · Education: $95.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,380.35 |
| Travel and Lodging | $1,758.89 |
| Education | $95.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,715.52 | 2024-2025 | Endurant Iis, Heli-Fx Endoanchor System, Venaseal |
| W. L. Gore & Associates, INC. | $1,529.84 | 2024-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Excluder Aaa Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Endologix LLC | $1,381.24 | 2024-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Inari Medical, INC. | $523.46 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Shape Memory Medical INC. | $123.92 | 2024-2025 | Impede Embolization Plug |
| Philips North America LLC | $116.67 | 2024 | (6582) Visions 035 |
| Kerecis Limited | $111.11 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Mimedx Group, INC. | $98.51 | 2024 | |
| Bard Peripheral Vascular, INC. | $90.38 | 2024 | Venovo, Covera, Venclose Maven Catheter |
| Silk Road Medical, INC. | $69.97 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cagent Vascular INC | $58.70 | 2024 | Serrantor |
| Ethicon US, LLC | $42.55 | 2024 | Prolene |
| Terumo Medical Corporation | $40.04 | 2024-2025 | Azur Cx Detachable, Navicross, Angio-Seal |
| Integra Lifesciences Corporation | $33.72 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bsn Medical INC | $30.70 | 2025 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $30.12 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Boston Scientific Corporation | $28.32 | 2025 | Eluvia |
| Vertex Pharmaceuticals Incorporated | $27.66 | 2025 | |
| Acera Surgical, INC. | $27.51 | 2024 | Restrata Wound Matrix |
| Biotronik INC. | $26.53 | 2025 | Orsiro Mission |
| Urgo Medical North America, LLC | $26.14 | 2025 | Urgok2 |
| Polynovo North America LLC | $25.18 | 2025 | Novosorb Btm |
| Abbott Laboratories | $23.07 | 2025 | Esprit |
| Smith+Nephew, INC. | $21.84 | 2025 | Collagenase Santyl |
| Tactile Systems Technology INC | $17.15 | 2025 | Flexitouch Plus, Nimbl |
| Hartmann USA, INC. | $15.34 | 2024 | Colactive Plus 2x2 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bird listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.